The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Oral Anticoagulants-Global Market Insights and Sales Trends 2024

Oral Anticoagulants-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1847214

No of Pages : 119

Ask Your Query
Synopsis
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
The global Oral Anticoagulants market size is expected to reach US$ 23590 million by 2029, growing at a CAGR of 7.1% from 2023 to 2029. The market is mainly driven by the significant applications of Oral Anticoagulants in various end use industries. The expanding demands from the Deep Vein Thrombosis (DVT), Pulmonary Embolism, Acute Coronary Syndrome and Hemodialysis, are propelling Oral Anticoagulants market. Direct Thrombin Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Direct Factor Xa Inhibitors segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Anticoagulants, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oral Anticoagulants market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oral Anticoagulants market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Anticoagulants sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oral Anticoagulants covered in this report include Johnson & Johnson, Bristol-Myers Squibb, Boehringer Ingelheim, Sanofi, Daiichi Sankyo, Armatheon, Aspen, AstraZeneca and Bayer, etc.
The global Oral Anticoagulants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson
Bristol-Myers Squibb
Boehringer Ingelheim
Sanofi
Daiichi Sankyo
Armatheon
Aspen
AstraZeneca
Bayer
Cellceutix
Cosmo Pharmaceuticals
CSL Behring
Eisai
GSK
Marathon Pharmaceuticals
Ockham Biotech
Perosphere
Global Oral Anticoagulants market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Anticoagulants market, Segment by Type:
Direct Thrombin Inhibitors
Direct Factor Xa Inhibitors
Global Oral Anticoagulants market, by Application
Deep Vein Thrombosis (DVT)
Pulmonary Embolism
Acute Coronary Syndrome
Hemodialysis
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oral Anticoagulants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oral Anticoagulants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Oral Anticoagulants Market Overview
1.1 Oral Anticoagulants Product Overview
1.2 Oral Anticoagulants Market Segment by Type
1.2.1 Direct Thrombin Inhibitors
1.2.2 Direct Factor Xa Inhibitors
1.3 Global Oral Anticoagulants Market Size by Type
1.3.1 Global Oral Anticoagulants Market Size Overview by Type (2018-2029)
1.3.2 Global Oral Anticoagulants Historic Market Size Review by Type (2018-2023)
1.3.3 Global Oral Anticoagulants Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oral Anticoagulants Sales Breakdown by Type (2018-2023)
1.4.2 Europe Oral Anticoagulants Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Oral Anticoagulants Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Oral Anticoagulants Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Oral Anticoagulants Sales Breakdown by Type (2018-2023)
2 Global Oral Anticoagulants Market Competition by Company
2.1 Global Top Players by Oral Anticoagulants Sales (2018-2023)
2.2 Global Top Players by Oral Anticoagulants Revenue (2018-2023)
2.3 Global Top Players by Oral Anticoagulants Price (2018-2023)
2.4 Global Top Manufacturers Oral Anticoagulants Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oral Anticoagulants Market Competitive Situation and Trends
2.5.1 Oral Anticoagulants Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Oral Anticoagulants Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Anticoagulants as of 2022)
2.7 Date of Key Manufacturers Enter into Oral Anticoagulants Market
2.8 Key Manufacturers Oral Anticoagulants Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oral Anticoagulants Status and Outlook by Region
3.1 Global Oral Anticoagulants Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Oral Anticoagulants Historic Market Size by Region
3.2.1 Global Oral Anticoagulants Sales in Volume by Region (2018-2023)
3.2.2 Global Oral Anticoagulants Sales in Value by Region (2018-2023)
3.2.3 Global Oral Anticoagulants Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Oral Anticoagulants Forecasted Market Size by Region
3.3.1 Global Oral Anticoagulants Sales in Volume by Region (2024-2029)
3.3.2 Global Oral Anticoagulants Sales in Value by Region (2024-2029)
3.3.3 Global Oral Anticoagulants Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Oral Anticoagulants by Application
4.1 Oral Anticoagulants Market Segment by Application
4.1.1 Deep Vein Thrombosis (DVT)
4.1.2 Pulmonary Embolism
4.1.3 Acute Coronary Syndrome
4.1.4 Hemodialysis
4.1.5 Others
4.2 Global Oral Anticoagulants Market Size by Application
4.2.1 Global Oral Anticoagulants Market Size Overview by Application (2018-2029)
4.2.2 Global Oral Anticoagulants Historic Market Size Review by Application (2018-2023)
4.2.3 Global Oral Anticoagulants Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oral Anticoagulants Sales Breakdown by Application (2018-2023)
4.3.2 Europe Oral Anticoagulants Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Oral Anticoagulants Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Oral Anticoagulants Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Oral Anticoagulants Sales Breakdown by Application (2018-2023)
5 North America Oral Anticoagulants by Country
5.1 North America Oral Anticoagulants Historic Market Size by Country
5.1.1 North America Oral Anticoagulants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Oral Anticoagulants Sales in Volume by Country (2018-2023)
5.1.3 North America Oral Anticoagulants Sales in Value by Country (2018-2023)
5.2 North America Oral Anticoagulants Forecasted Market Size by Country
5.2.1 North America Oral Anticoagulants Sales in Volume by Country (2024-2029)
5.2.2 North America Oral Anticoagulants Sales in Value by Country (2024-2029)
6 Europe Oral Anticoagulants by Country
6.1 Europe Oral Anticoagulants Historic Market Size by Country
6.1.1 Europe Oral Anticoagulants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Oral Anticoagulants Sales in Volume by Country (2018-2023)
6.1.3 Europe Oral Anticoagulants Sales in Value by Country (2018-2023)
6.2 Europe Oral Anticoagulants Forecasted Market Size by Country
6.2.1 Europe Oral Anticoagulants Sales in Volume by Country (2024-2029)
6.2.2 Europe Oral Anticoagulants Sales in Value by Country (2024-2029)
7 Asia-Pacific Oral Anticoagulants by Region
7.1 Asia-Pacific Oral Anticoagulants Historic Market Size by Region
7.1.1 Asia-Pacific Oral Anticoagulants Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Oral Anticoagulants Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Oral Anticoagulants Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Oral Anticoagulants Forecasted Market Size by Region
7.2.1 Asia-Pacific Oral Anticoagulants Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Oral Anticoagulants Sales in Value by Region (2024-2029)
8 Latin America Oral Anticoagulants by Country
8.1 Latin America Oral Anticoagulants Historic Market Size by Country
8.1.1 Latin America Oral Anticoagulants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Oral Anticoagulants Sales in Volume by Country (2018-2023)
8.1.3 Latin America Oral Anticoagulants Sales in Value by Country (2018-2023)
8.2 Latin America Oral Anticoagulants Forecasted Market Size by Country
8.2.1 Latin America Oral Anticoagulants Sales in Volume by Country (2024-2029)
8.2.2 Latin America Oral Anticoagulants Sales in Value by Country (2024-2029)
9 Middle East and Africa Oral Anticoagulants by Country
9.1 Middle East and Africa Oral Anticoagulants Historic Market Size by Country
9.1.1 Middle East and Africa Oral Anticoagulants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Oral Anticoagulants Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Oral Anticoagulants Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Oral Anticoagulants Forecasted Market Size by Country
9.2.1 Middle East and Africa Oral Anticoagulants Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Oral Anticoagulants Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Oral Anticoagulants Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Johnson & Johnson Oral Anticoagulants Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 Bristol-Myers Squibb
10.2.1 Bristol-Myers Squibb Company Information
10.2.2 Bristol-Myers Squibb Introduction and Business Overview
10.2.3 Bristol-Myers Squibb Oral Anticoagulants Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bristol-Myers Squibb Oral Anticoagulants Products Offered
10.2.5 Bristol-Myers Squibb Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Oral Anticoagulants Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boehringer Ingelheim Oral Anticoagulants Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Oral Anticoagulants Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Oral Anticoagulants Products Offered
10.4.5 Sanofi Recent Development
10.5 Daiichi Sankyo
10.5.1 Daiichi Sankyo Company Information
10.5.2 Daiichi Sankyo Introduction and Business Overview
10.5.3 Daiichi Sankyo Oral Anticoagulants Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Daiichi Sankyo Oral Anticoagulants Products Offered
10.5.5 Daiichi Sankyo Recent Development
10.6 Armatheon
10.6.1 Armatheon Company Information
10.6.2 Armatheon Introduction and Business Overview
10.6.3 Armatheon Oral Anticoagulants Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Armatheon Oral Anticoagulants Products Offered
10.6.5 Armatheon Recent Development
10.7 Aspen
10.7.1 Aspen Company Information
10.7.2 Aspen Introduction and Business Overview
10.7.3 Aspen Oral Anticoagulants Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Aspen Oral Anticoagulants Products Offered
10.7.5 Aspen Recent Development
10.8 AstraZeneca
10.8.1 AstraZeneca Company Information
10.8.2 AstraZeneca Introduction and Business Overview
10.8.3 AstraZeneca Oral Anticoagulants Sales, Revenue and Gross Margin (2018-2023)
10.8.4 AstraZeneca Oral Anticoagulants Products Offered
10.8.5 AstraZeneca Recent Development
10.9 Bayer
10.9.1 Bayer Company Information
10.9.2 Bayer Introduction and Business Overview
10.9.3 Bayer Oral Anticoagulants Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Bayer Oral Anticoagulants Products Offered
10.9.5 Bayer Recent Development
10.10 Cellceutix
10.10.1 Cellceutix Company Information
10.10.2 Cellceutix Introduction and Business Overview
10.10.3 Cellceutix Oral Anticoagulants Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Cellceutix Oral Anticoagulants Products Offered
10.10.5 Cellceutix Recent Development
10.11 Cosmo Pharmaceuticals
10.11.1 Cosmo Pharmaceuticals Company Information
10.11.2 Cosmo Pharmaceuticals Introduction and Business Overview
10.11.3 Cosmo Pharmaceuticals Oral Anticoagulants Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Cosmo Pharmaceuticals Oral Anticoagulants Products Offered
10.11.5 Cosmo Pharmaceuticals Recent Development
10.12 CSL Behring
10.12.1 CSL Behring Company Information
10.12.2 CSL Behring Introduction and Business Overview
10.12.3 CSL Behring Oral Anticoagulants Sales, Revenue and Gross Margin (2018-2023)
10.12.4 CSL Behring Oral Anticoagulants Products Offered
10.12.5 CSL Behring Recent Development
10.13 Eisai
10.13.1 Eisai Company Information
10.13.2 Eisai Introduction and Business Overview
10.13.3 Eisai Oral Anticoagulants Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Eisai Oral Anticoagulants Products Offered
10.13.5 Eisai Recent Development
10.14 GSK
10.14.1 GSK Company Information
10.14.2 GSK Introduction and Business Overview
10.14.3 GSK Oral Anticoagulants Sales, Revenue and Gross Margin (2018-2023)
10.14.4 GSK Oral Anticoagulants Products Offered
10.14.5 GSK Recent Development
10.15 Marathon Pharmaceuticals
10.15.1 Marathon Pharmaceuticals Company Information
10.15.2 Marathon Pharmaceuticals Introduction and Business Overview
10.15.3 Marathon Pharmaceuticals Oral Anticoagulants Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Marathon Pharmaceuticals Oral Anticoagulants Products Offered
10.15.5 Marathon Pharmaceuticals Recent Development
10.16 Ockham Biotech
10.16.1 Ockham Biotech Company Information
10.16.2 Ockham Biotech Introduction and Business Overview
10.16.3 Ockham Biotech Oral Anticoagulants Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Ockham Biotech Oral Anticoagulants Products Offered
10.16.5 Ockham Biotech Recent Development
10.17 Perosphere
10.17.1 Perosphere Company Information
10.17.2 Perosphere Introduction and Business Overview
10.17.3 Perosphere Oral Anticoagulants Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Perosphere Oral Anticoagulants Products Offered
10.17.5 Perosphere Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oral Anticoagulants Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oral Anticoagulants Industrial Chain Analysis
11.4 Oral Anticoagulants Market Dynamics
11.4.1 Oral Anticoagulants Industry Trends
11.4.2 Oral Anticoagulants Market Drivers
11.4.3 Oral Anticoagulants Market Challenges
11.4.4 Oral Anticoagulants Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oral Anticoagulants Distributors
12.3 Oral Anticoagulants Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock